Lon Cardon's most recent trade in Mirum Pharmaceuticals Inc was a trade of 3,772 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 3,772 | 3,772 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 1,980 | 1,980 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Lon Cardon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2026 | 3,977 | 0 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Lon Cardon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2026 | 3,977 | 9,680 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 6,268 | 6,268 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Lon Cardon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 5,703 | 0 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Lon Cardon | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 May 2025 | 5,703 | 5,703 (0%) | 0% | - | Common Stock | |
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 May 2025 | 3,977 | 3,977 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 8,779 | 8,779 | - | - | Stock Option (right to buy) | |
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 5,703 | 5,703 | - | - | Restricted Stock Units | |
| Mirum Pharma Inc | Lon Cardon | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2023 | 7,083 | 7,083 | - | - | Stock Option (right to buy) |